Emad
Abu Assi
Publikationen, an denen er mitarbeitet Emad Abu Assi (65)
2022
-
Differences Between Takotsubo and the Working Diagnosis of Myocardial Infarction With Nonobstructive Coronary Arteries
Frontiers in Cardiovascular Medicine, Vol. 9
2021
-
Evaluation of optimal medical therapy in acute myocardial infarction patients with prior stroke
Therapeutic Advances in Chronic Disease, Vol. 12
2020
-
Incidence, predictors and prognostic impact of intracranial bleeding within the first year after an acute coronary syndrome in patients treated with percutaneous coronary intervention
European Heart Journal: Acute Cardiovascular Care, Vol. 9, Núm. 7, pp. 764-770
-
P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects
European heart journal. Cardiovascular pharmacotherapy, Vol. 6, Núm. 1, pp. 31-42
-
The impact of optimal medical therapy on patients with recurrent acute myocardial infarction: Subanalysis from the BleeMACS study
International Journal of Cardiology, Vol. 318, pp. 1-6
2018
-
Association of Beta-Blockers with Survival on Patients Presenting with ACS Treated with PCI: A Propensity Score Analysis from the BleeMACS Registry
American Journal of Cardiovascular Drugs, Vol. 18, Núm. 4, pp. 299-309
-
Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS score
International Journal of Cardiology, Vol. 254, pp. 10-15
-
Gender-related differences in post-discharge bleeding among patients with acute coronary syndrome on dual antiplatelet therapy: A BleeMACS sub-study
Thrombosis Research, Vol. 168, pp. 156-163
-
Prediction of Post-Discharge Bleeding in Elderly Patients with Acute Coronary Syndromes: Insights from the BleeMACS Registry
Thrombosis and Haemostasis, Vol. 118, Núm. 5, pp. 929-938
-
Prevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: a BleeMACS substudy
European heart journal. Acute cardiovascular care, Vol. 7, Núm. 7, pp. 631-638
2017
-
Complete or incomplete coronary revascularisation in patients with myocardial infarction and multivessel disease: A propensity score analysis from the "real-life" BleeMACS (Bleeding complications in a Multicenter registry of patients discharged with diagnosis of Acute Coronary Syndrome) registry
EuroIntervention, Vol. 13, Núm. 4, pp. 407-414
-
Impact of triple antithrombotic therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention in real-world practice
Journal of Geriatric Cardiology, Vol. 14, Núm. 11, pp. 679-687
-
Optimal Medical Therapy in Patients with Malignancy Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome: a BleeMACS Sub-Study
American Journal of Cardiovascular Drugs, Vol. 17, Núm. 1, pp. 61-71
2016
-
24 h nesfatin-1 treatment promotes apoptosis in cardiomyocytes
Endocrine
-
BleeMACS: Rationale and design of the study
Journal of Cardiovascular Medicine, Vol. 17, Núm. 10, pp. 744-749
-
Comparación entre tres sistemas de puntuación de hemorragia en pacientes con fibrilación auricular no valvular. ¿Qué puede ofrecer la nueva puntuación ORBIT?
Revista Espanola de Cardiologia, Vol. 69, Núm. 11, pp. 1112-1114
-
Dominancia coronaria como factor pronóstico: ¿también en infartos anteriores? Respuesta
Revista Espanola de Cardiologia
-
Dominancia coronaria y pronóstico a largo plazo de los pacientes con infarto de miocardio con elevación del segmento ST tratado con angioplastia primaria
Revista Espanola de Cardiologia, Vol. 69, Núm. 1, pp. 19-27
-
El riesgo de eventos cardiovasculares tras un evento coronario agudo persiste elevado a pesar de la revascularización, especialmente durante el primer año
Revista Espanola de Cardiologia, Vol. 69, Núm. 1, pp. 11-18
-
Endolysosomal two-pore channels regulate autophagy in cardiomyocytes
Journal of Physiology, Vol. 594, Núm. 11, pp. 3061-3077